Bayer CropScience (506285) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
5 Aug, 2026Executive summary
Revenue from operations for the quarter ended June 30, 2026, was ₹18,350 million, up from ₹11,008 million in the same quarter last year.
Profit before tax for the quarter was ₹4,021 million, compared to ₹2,064 million year-over-year.
Net profit for the quarter reached ₹3,216 million, up from ₹1,621 million in the prior year quarter.
Financial highlights
Total income for the quarter was ₹19,239 million, compared to ₹11,474 million in the same quarter last year.
Earnings per share (basic and diluted) for the quarter were ₹71.56, up from ₹36.07 year-over-year.
Other income included a ₹639 million gain on divestment of marketing rights for formulated products.
Outlook and guidance
Business is seasonal, and quarterly figures are not necessarily indicative of full-year performance.
Latest events from Bayer CropScience
- Revenue and net profit increased year-over-year, with robust cash flow and higher EPS.506285
Q4 25/26 - Six-month net profit reached ₹4,314 million with a ₹90/share interim dividend declared.506285Q2 25/26
- Q1 FY25 net profit reached ₹2,542 million, with a ₹155 million impairment on Glyphosate assets.506285Q1 24/25
- Revenue up, but profit down on asset impairment; interim dividend of ₹90 per share declared.506285Q2 24/25
- Revenue up but profits down as impairment hits margins; business remains highly seasonal.506285Q3 24/25
- FY25 revenue rose but net profit declined due to asset impairment; ₹35/share dividend proposed.506285Q4 24/25
- Five-year strategy targets EUR 25B+ sales, mid-20s margin, and clean audit for Q2 2025.506285Q1 25/26